109314 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines Colony stimulating factors (G-CSF, GM-CSF)
PREPARATION METHOD FOR ADENOVIRUS P53-LOADED DENDRITIC CELL VACCINE
#2LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME
#3System and Method For Converting Adipose Derived Mesenchymal Stem Cells To Hematopoietic Stem/Progenitor Cells And Differentiating Into Blood Cells And Applications Of Same
#4MICROGLIA DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME
#5THERAPEUTIC MACROPHAGES
#6METHODS FOR ENGRAFTING BONE MARROW ORGANOIDS
#7METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#8NATURAL KILLER CELLS
#9Induction and Expansion of Regulatory T Cells
#10CELLS FOR THERAPY
#11DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#12METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#13NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#14CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL
#15METHOD FOR PRODUCING MATURE DENDRITIC CELLS
#16CELL CULTURE MEDIUM
#17RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS
#18Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#19CANCER-KILLING CELLS
#20ENGINEERED PROGENITOR CELLS AND METHODS OF USE
#21ISOLATION OF ANTI-INFLAMMATORY NEUTROPHIL OR MONOCYTE SUBSET AND USE IN TREATING CARDIOVASCULAR DISEASES
#22Gene Therapy
#23COMPOSITIONS AND METHODS FOR NEURALGENESIS
#24MACROPHAGE-BASED THERAPY
#25Adenoviral Vector Transduced Apheresis Product
#26ENGINEERED CELLS AND USES THEREOF
#27METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN
#28REPROGRAMMING OF IMMUNE-ENHANCING NEUTROPHILS BY SUBCLINICAL LOW-DOSE ENDOTOXIN FOR THE TREATMENT OF CANCER
#29COMPOSITIONS AND METHODS FOR ACTIVATING IMMUNE CELLS
#30CULTURE MEDIUM AND METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN MACROPHAGES AND USE THEREOF
#31METHOD FOR PRODUCING PROLIFERATIVE MACROPHAGE-LIKE CELLS (pMAC)
#32CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#33GENERATING BONE MARROW ORGANOIDS
#34METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES
#35Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#36BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#37CRISPR-MEDIATED DELETION OF FLI1 IN NK CELLS
#38METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITION FOR TREATING CANCER
#39CELL CULTURE MEDIA AND METHODS FOR GENERATING HUMAN ALVEOLAR MACROPHAGE-LIKE CELLS
#40TRANSGENIC T CELL RECEPTORS TARGETING NEOANTIGENS FOR DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF HEMATOLOGICAL CANCERS
#41PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#42Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates
#43METHOD FOR PRODUCING PLURIPOTENT STEM CELLS
#44DIFFERENTIATION AND USE OF HUMAN MICROGLIA-LIKE CELLS FROM PLURIPOTENT STEM CELLS AND HEMATOPOIETIC PROGENITORS
#45METHODS AND SYSTEMS FOR CULTURING ORGANOIDS
#46Method for the Generation of Non-Transformed Macrophage Cell Line
#47Induction of Antigen Specific Immunological Tolerance Using Inducible Pluripotent Stem Cell Derived Veto Cells
#48Adenoviral vector transduced apheresis product
#49ACTIVATION OF SURVIVIN-SPECIFIC IMMUNE RESPONSES USING DENDRITIC CELL DERIVED EXOSOMES
#50IPSC-DERIVED IMMUNE CELLS IN PROPHYLAXIS AND TREATMENT OF AGE-ASSOCIATED AND NEURODEGENERATIVE DISEASES
#51BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF
#52Culture Medium and Culture Method for Human Primary Acute Myeloid Leukemia Cells
#53METHODS OF TREATING CANCER
#54MonoMac-1 Cells Expressing CD16 and CD163
#55TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF
#56SYSTEM AND METHOD FOR CONVERTING ADIPOSE DERIVED MESENCHYMAL STEMS CELLS TO HEMATOPOIETIC STEM/PROGENITOR CELLS AND DIFFERENTIATING INTO BLOOD CELLS AND APPLICATIONS OF SAME
#57METHOD FOR IMPROVING PROLIFERATIVE PROPERTIES OF COMMON MYELOID PROGENITOR CELLS (CMP) OR MYELOCYTIC PROGENITOR CELLS
#58METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF
#59COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#60COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN
#61HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#62PHARMACEUTICAL USE OF CORD BLOOD IMMUNOSUPPRESSIVE CELL
#63METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
#64CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY
#65CANCER-KILLING CELLS
#66CELL CULTURE SURFACES AND CONTAINERS AND METHODS FOR MAKING AND USING THEM
#67METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#68TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS
#69METHOD FOR OBTAINING TUMOR-HYPOXIA EDUCATED REGENERATIVE MACROPHAGES AND USE THEREOF IN REGENERATIVE MEDICINE
#70PREPARATION METHOD AND APPLICATION OF CTL CELL
#71Human Cross-Presenting CD141+CLEC9A+ Dendritic Cells, Methods of Producing the Same from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells and Methods of Use
#72RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH CD14 PROMOTER AND USE THEREOF
#73METHOD FOR T-CELL EXPANSION AND RELATED MEDICAL APPLICATIONS
#74NEW REGULATORY MACROPHAGES AND USES THEREOF
#75METHOD FOR DIFFERENTIATING PLURIPOTENT STEM CELL-DERIVED HEMOGENIC ENDOTHELIAL CELLS INTO LYMPHOID LINEAGE CELLS
#76NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF
#77HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#78ADIPOGENIC CELL COMPOSITIONS AND METHODS
#79METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY
#80METHODS FOR EXPANDING A POPULATION OF ALVEOLAR MACROPHAGES IN A LONG TERM CULTURE
#81GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS
#82Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#83GENETICALLY ENGINEERED DENDRITIC CELLS TO ACTIVATE PROTEIN SPECIFIC T CELLS FOR THE TREATMENT OF VIRAL AND OTHER PATHOGENIC INFECTIONS
#84Use of CDK Inhibitors to Enhance Growth and Self-Renewal of Progenitor Cells
#85METHODS AND MATERIALS FOR EXPANDING ANTIGEN-SPECIFIC T CELLS IN CULTURE
#86CANCER-KILLING CELLS
#87Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors
#88ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME
#89SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof
#90STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS
#91METHODS FOR SPERMATOGONIAL CULTURE
#92Methods, kits, and compositions for enhancing cellular therapy
#93NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#94METHOD OF PRODUCING MACROPHAGES
#95COMPOSITIONS AND METHODS OF GENERATING AN IMMUNE RESPONSE
#96SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF
#97METHOD OF MICROGLIA DIFFERENTIATION CAPABLE OF SECURING LARGE QUANTITY OF MICROGLIA BY USING 3D ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
#98METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#99METHOD FOR OBTAINING CAR-NK CELLS
#100AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USES
#101HYPOIMMUNOGENIC CELLS
#102COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF
#103METHOD FOR THE PRODUCTION OF MATURE DENDRITIC CELLS IN VITRO USING A BACTERIAL LYSATE
#104PREVENTION OF RECURRENT MISCARRIAGES THROUGH ADMINISTRATION OF FIBROBLASTS AND FIBROBLAST-EDUCATED PATERNAL CELLS
#105FIBROBLAST-BASED IMMUNOTHERAPY OF GRAVES DISEASE
#106MODIFIED MACROPHAGES, COMPOSITIONS AND USES THEREOF
#107NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
#108NOVEL METHOD
#109METHOD FOR PRODUCING HUMAN PROFESSIONAL ANTIGEN-PRESENTING CELLS
#110MATURATION OF SPERMATOGONIAL CELLS IN VITRO BT GROWTH FACTORS AND HORMONES
#111TEMPERATURE-BASED TRANSIENT DELIVERY OF ZSCAN4 NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES
#112GENERATION OF MATURE KUPFFER CELLS
#113EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS
#114NATURAL KILLER CELLS
#115Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity
#116Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#117Method for treating type I diabetes with peptide-loaded dendritic cells
#118Method for treating multiple sclerosis with peptide-loaded dendritic cells
#119Use of LRP2 agonists for generating myeloid-derived suppressor cells
#120COMPOSITIONS FOR REPROGRAMMING CELLS INTO DENDRITIC CELLS OR ANTIGEN PRESENTING CELLS, METHODS AND USES THEREOF
#121Biocompatible conditioned cell medium compositions and uses thereof
#122Cell culture media and methods for generating human alveolar macrophage-like cells
#123CHIMERIC CELLS COMPRISING DENDRITIC CELLS AND ENDOTHELIAL CELLS RESEMBLING TUMOR ENDOTHELIUM
#124Systems for producing cellular immunotherapeutics and methods of use thereof
#125POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR
#126EX VIVO GENERATION OF IMMUNOCYTES RECOGNIZING BROTHER OF THE REGULATOR OF IMPRINTED SITES (BORIS) EXPRESSING CANCER STEM CELLS
#127Improved Retinal Organoids And Methods Of Making The Same
#128POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS
#129BOVINE MONOCYTE-DERIVED MACROPHAGE IN CULTURE SYSTEM AND METHODS FOR MEASURING INNATE IMMUNITY
#130LOW DENSITY CELL CULTURE
#131BONE MARROW MICROGLIA PROGENITOR CELLS AND USES THEREOF
#132RAPID AND DETERMINISTIC GENERATION OF MICROGLIA FROM HUMAN PLURIPOTENT STEM CELLS
#133MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#134COMPOSITION FOR INDUCING DIRECT CONVERSION OF SOMATIC CELL INTO COMMON MYELOID PROGENITOR AND USE THEREOF
#135Method for long-term ex vivo maintenance or expansion of human erythroblast, human megakaryocyte-erythroid progenitor, or human common myeloid progenitor cell and application thereof
#136METHOD FOR PREPARATION OF CANCER/TESTIS ANTIGEN-SPECIFIC T-CELLS
#137COMPOSITION FOR TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#138Method of generating hemangioblasts
#139CRYOPRESERVATION AND CELL CULTURE MEDIA
#140Methods of treating cancers with CT45 targeted therapies
#141OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE
#142METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#143Recombinant adeno-associated virus vectors with CD14 promoter and use thereof
#144EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THERAPEUTIC USES THEREOF
#145Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof
#146MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES
#147MICROGLIA-SUFFICIENT BRAIN ORGANOIDS
#148CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF RIBOSOMAL PROTEIN S19 (RPS19) GENE
#149COLONY FORMING MEDIUM AND USE THEREOF
#150VIRUS SPECIFIC CYTOKINE-INDUCED KILLER CELLS
#151CHARACTERIZATION OF BONE MARROW USING CELL-FREE MESSENGER-RNA
#152BACTERIA-DERIVED VESICLES AND USES THEREOF
#153METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
#154CAR NK cells
#155DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#156FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#157QUALITY OF A CELLULAR GRAFT
#158Methods and reagents for modulating macrophage phenotype
#159THERAPEUTIC GENE EDITING FOR ELANE-ASSOCIATED DISEASE
#160NOVEL C-MET AND TMX2 ANTIBODIES
#161MICROGLIA DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME
#162Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
#163HIGH-EFFICIENCY METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS
#164METHOD FOR EXPANDING HUMAN DC CELL AND HUMAN DC CELL RESOURCE LIBRARY
#165METHOD FOR AMPLIFYING ANTIGEN-SPECIFIC REGULATORY T CELLS IN VITRO
#166METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES
#167FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#168THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
#169METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF
#170ORGANOID COMPOSITIONS FOR THE PRODUCTION OF HEMATOPOIETIC STEM CELLS AND DERIVATIVES THEREOF
#171METHODS, KITS, AND COMPOSITIONS FOR ENHANCING CELLULAR THERAPY
#172Mammalian alveolar macrophages derived from pluripotent cells
#173Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof
#174Engineered Cells for Inducing Tolerance
#175BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#176Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#177METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#178UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF
#179Methods and compositions for inducing hematopoietic cell differentiation
#180Development of dual whole cell-based vaccine against pancreatic cancer
#181STEM CELL-DERIVED HUMAN MICROGLIAL CELLS, METHODS OF MAKING AND METHODS OF USE
#182Cancer-killing cells
#183STEM-CELL DERIVED MYELOID CELLS, GENERATION AND USE THEREOF
#184METHOD FOR THE IN VITRO DIFFERENTIATION AND MATURATION OF DENDRITIC CELLS FOR THERAPEUTIC USE
#185Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#186TRANSPOSON SYSTEM AND METHODS OF USE
#187Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#188Methods and compositions for inducing hematopoietic cell differentiation
#189EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#190METHOD FOR INCREASING DENDRITIC CELL MIGRATION ABILITY, AND USE THEREOF
#191FIXED RATIO EX VIVO ACTIVATED MIXED LYMPHOCYTE PRODUCTS FOR USE IN THE TREATMENT OF CANCER
#192Method of producing natural killer cells and composition for treating cancer
#193METHOD OF PRODUCING ERYTHROCYTES
#194Methods and compositions for inducing hematopoietic cell differentiation
#195Methods for directed differentiation of pluripotent stem cells to immune cells
#196Method for activating T cells for cancer treatment
#197METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#198Macrophage-based therapy
#199Differentiation of pluripotent cells into microglial cells expressing IBA-1
#200Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
#201GERIATRIC CAR-T CELLS AND USES THEREOF
#202T-reg cell expansion
#203Methods, kits, and compositions for enhancing cellular therapy
#204NATURAL KILLER CELLS AND USES THEREOF
#205Method for producing myeloid-derived suppressor cells, myeloid-derived suppressor cells produced thereby, and methods thereof
#206NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#207Method for activating T cells for cancer treatment
#208Methods of preparing hematopoietic progenitor cells in vitro
#209Methods and compositions for inducing hematopoietic cell differentiation
#210Methods and materials for expanding antigen-specific T cells in culture
#211DIFFERENTIATION AND USE OF HUMAN MICROGLIA-LIKE CELLS FROM PLURIPOTENT STEM CELLS AND HEMATOPOIETIC PROGENITORS
#212METHODS AND COMPOSITIONS FOR REJUVENATION
#213Method of producing natural killer cells and composition for treating cancer
#214MEDIUM SYSTEM AND METHOD FOR EX VIVO EXPANSION OF NK CELLS
#215Differentiation Of Immunocytes Using Pluripotent Stem Cells
#216METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS
#217Compositions and methods for neuralgenesis
#218Biocompatible conditioned cell medium compositions and uses thereof
#219METHODS OF EXTRACTING HEMATOPOIETIC CELLS FROM BONE MARROW EX VIVO
#220METHODS OF IMPROVING HEMATOPOIETIC GRAFTS
#221MonoMac-1 cells expressing CD16 and CD163
#222Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
#223Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
#224Compositions and methods for maturation of oocytes in vitro
#225Method of producing natural killer cells and composition for treating cancer
#226DENDRITIC CELL PREPARATIONS, COMPOSITIONS THEREOF AND METHODS OF USING SAME
#227Cancer-killing cells
#228Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
#229Methods and reagents for modulating macrophage phenotype
#230Cancer vaccines and vaccination methods
#231METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS
#232Induced dendritic cells and uses thereof
#233METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
#234Macrophage-based therapy for use in the treatment of liver injury
#235Generation of HPV-specific T-cells
#236Compositions and methods to derive mesodermal lineage cells and mixed tissue organoids from embryonic stem cells
#237Induced pluripotent stem cells produced from dendritic cells
#238METHOD FOR MEASURING IMMUNOGENICITY OF PROTEIN AGENT
#239Method for obtaining microglia from pluripotent stem cells
#240SUPPORT FOR CULTURING CELLS, METHOD OF PREPARING SUPPORT, AND METHOD OF CULTURING CELLS
#241Regulated biocircuit systems
#242Ex vivo generation of γδ Foxp3regulatory T cells and therapeutic uses thereof
#243Ex vivo generation of MHCII restricted CD4FOXP3regulatory T cells and therapeutic uses thereof
#244Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells
#245Methods of treating cancers with CT45 targeted therapies
#246Methods of expanding myeloid cell populations and uses thereof
#247Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
#248Development of dual whole cell-based vaccine against pancreatic cancer
#249Derivation of human microglia from pluripotent stem cells
#250Colony forming medium and use thereof
#251Methods to mobilize tissue resident cells for adoptive t cell therapy
#252BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#253Compositions and methods for neuralgenesis
#254METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS
#255Induction medium and methods for stem cell culture and therapy
#256Generation of antigen-specific TCRs
#257Dendritic cell composition
#258Therapeutic cancer vaccines derived from a novel dendritic cell line
#259Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#260Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#261KIDNEY-SPECIFIC TUMOR VACCINE DIRECTED AGAINST KIDNEY TUMOR ANTIGEN G-250
#262TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES THEREOF
#263MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#264RECONSTITUTING HEMATOPOIETIC CELL FUNCTION USING HUMAN EMBRYONIC STEM CELLS
#265NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
#266Use of CDK inhibitors to enhance growth and self-renewal of progenitor cells
#267Methods and Compositions for Enhancing Transduction Efficiency of Retroviral Vectors
#268PROCESS OF GENE-EDITING OF CELLS ISOLATED FROM A SUBJECT SUFFERING FROM A METABOLIC DISEASE AFFECTING THE ERYTHROID LINEAGE, CELLS OBTAINED BY SAID PROCESS AND USES THEREOF
#269Methods and compositions for inducing hematopoietic cell differentiation
#270Methods for directed differentiation of pluripotent stem cells to immune cells
#271ISOLATION, EXPANSION AND USE OF CLONOGENIC ENDOTHELIAL PROGENITOR CELLS
#272Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#273METHODS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
#274COMPOSITIONS HAVING ANTI-FUGETACTIC PROPERTIES FOR TREATMENT OF CANCER
#275Systems for producing cellular immunotherapeutics and methods of use thereof
#276Generation of HPV-specific T-cells
#277Methods and materials for expanding antigen-specific T cells in culture
#278Fusion molecule based on TAA variant
#279Method for Inducing Differentiation of Myeloid-Derived Suppressor Cells from Cord - Blood CD34 Positive Cells and Proliferating Same, and use of Myeloid-Derived
#280Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#281Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
#282SERUM-FREE CULTURE MEDIUM AND METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS
#283Method for generating human dendritic cells for immunotherapy
#284Enrichment of CD16+ monocytes to improve dendritic cell vaccine quality
#285T-REG cell expansion
#286MULTIPOTENT STEM CELLS AND USES THEREOF
#287MULTIPOTENT STEM CELLS AND USES THEREOF
#288METHOD FOR ANTIGEN LOADING OF DENDRITIC CELLS AND VACCINE
#289METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#290Multipotent stem cells and uses thereof
#291Ex vivo NK cell differentiation from CD34 hematopoietic cells
#292METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#293SOMATIC STEM CELLS
#294Method of differentiating human pluripotent stem cells into primitive macrophages
#295NATURAL KILLER CELLS AND USES THEREOF
#296Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
#297Tolerogenic dendritic cells, methods of producing the same, and uses thereof
#298Mammalian alveolar macrophages derived from pluripotent cells
#299Co-differentiation of monocytes from allogeneic donors
#300MULTIPOTENT STEM CELLS AND USES THEREOF